Prevnar 20

Merck strides onto Pfizer’s turf, posting pivotal vaccine data and heading to regulators
Fierce Pharma
Tue, 11/28/23 - 11:52 am
Merck
Pfizer
vaccines
clinical trials
pneumococcal disease
V116
Prevnar 20
Pfizer wins FDA nod for Prevnar 20 pneumonia vaccine in children
Seeking Alpha
Thu, 04/27/23 - 10:56 pm
Pfizer
vaccines
FDA
Prevnar 20
pneumococcal disease
pediatric
FDA grants priority reviews for Pfizer's Prevnar 20 for kids and Roche lymphoma candidate
Endpoints
Sun, 01/8/23 - 09:59 pm
FDA
priority review
Pfizer
Prevnar 20
vaccines
Roche
bispecific antibodies
glofitamab
lymphoma
After going head-to-head with Prevnar 20, Vaxcyte's 24-valent pneumococcal shot will seek a pivotal win
Endpoints
Mon, 10/24/22 - 11:19 am
Vaxcyte
vaccines
VAX-24
pneumococcal disease
Pfizer
Prevnar 20
clinical trials
Pfizer's 20-valent pneumococcal vaccine hits goal in infant trial, teeing up 2022 approval filing
Fierce Biotech
Fri, 08/12/22 - 10:16 am
Pfizer
vaccines
Prevnar 20
FDA
infants
clinical trials
pneumococcal disease
Pfizer, Merck next-gen pneumococcal vaccines score key CDC panel's backing on way to rival rollouts
Fierce Pharma
Thu, 10/21/21 - 11:20 pm
Pfizer
Merck
pneumococcal disease
vaccines
Prevnar 20
Vaxneuvance
CDC
Pfizer's next-gen Prevnar 20 can be administered with a flu shot, study finds
Fierce Pharma
Wed, 09/29/21 - 11:14 am
Pfizer
Prevnar 20
vaccines
flu vaccines
COVID-19
Can Merck Beat Pfizer in This Multibillion-Dollar Vaccine Market?
Motley Fool
Sun, 08/1/21 - 11:50 pm
Merck
Pfizer
vaccines
Vaxneuvance
Prevnar 20
pneumococcal disease
Pfizer rolls out next-gen pneumococcal vaccine with FDA win, beating Merck's 15-valent candidate to the punch
Endpoints
Wed, 06/9/21 - 11:54 am
Pfizer
FDA
Merck
pneumococcal disease
vaccines
Prevnar 20